Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Req ID:517518 At Alstom, we understand transport networks and what moves people. From high-speed trains, metros, monorails, and trams, to turnkey systems, services, infrastructure, signalling and digital mobility, we offer our diverse customers the broadest portfolio
Requisition ID: 7776 Grade: ISA-P3 Country: Austria Duty Station: Vienna Category: International Consultant Type of Job Posting: Internal and External Employment Type: NonStaff-Regular Contract Duration: 6 months Application Deadline: 23-Jul-2026, 11:59 PM (Vienna, Austria time) Vacancy